Go Medical Industries Pty Ltd   Report issue

For profit Phase 2
Founded: Subiaco Australia (1986)
Status: No NME R&D (1986)

Organization Overview

First Clinical Trial
2019
NCT03810495
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Go Medical Industries Pty Ltd

Active Ingredients

Drugs in Phase 2 Trials (1)

naltrexone (revia) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Substance-Related Disorders (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1